Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient | PTCE Pharmacy Connect

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Educational Objectives

• Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management
• Explain patient education and counseling for managing hypercholesteremia

Faculty:

Joseph Saseen, PharmD, BCPS, BCACP, CLS

Professor and Associate Dean for Clinical Affairs

University of Colorado Anschutz Medical Campus

Skaggs School of Pharmacy and Pharmaceutical Sciences

Aurora, Colorado

 

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Executive Director, Ambulatory Pharmacy Services

Grady Health System

Atlanta, Georgia

Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose:

Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))

 

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Novartis

Consultant: Novartis, Regeneron

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.

 

This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.

 

Please follow the link below to access this activity on PTCE and claim CE credit:

www.pharmacytimes.org/hyperlipidemiapodcast